Approval · Notice of Compliance 35907 · 2025
FEMYSO: Notice of Compliance 35907
Issued August 26, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35907
- Date
- August 26, 2025
- Company
- Lupin Pharma Canada LimitedLongueuil, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- MEFEGYMISO (Linepharma International Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FEMYSO | 02560569 | Marketed |
Medicinal ingredients
- MISOPROSTOL 200 MCG per TAB
- MIFEPRISTONE 200 MG per TAB